新型冠状病毒肺炎疫情期回望氯喹发展史

Abstract
Figure/Table
References
Related Citation (15)

[1]	Salata C, Calistri A, Parolin C, et al. Coronaviruses: a paradigm of new emerging zoonotic diseases[J]. Pathog Dis. 2020 Feb 17. pii: ftaa006. doi: 10.1093/femspd/ftaa006.[Epub ahead of print].
[2]	Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, doi: 10.1056/ NEJMoa2001017.[Epub ahead of print].
[3]	国家卫生健康委办公厅.关于印发新型冠状病毒肺炎防控方案 (第五版)的通知疾病预防控制局国卫办疾控函〔2020〕103号[EB/OL]. (2020-02-06)[2020-02-14]. http://www.nhc.gov.cn/jkj.
[4]	Klein W, Pieter T. The hidden history of a famous drug: tracing the medical and public acculturation of peruvian bark in early modern Western Europe (c. 1650-1720)[J]. J Hist Med Allied Sci, 2016, 71: 400-421.
[5]	Earle D. Presidential address: a history of malaria and its ironies [J]. Trans Am Clin Climatol Assoc, 1979, 90: 1-26.
[6]	Harrison N. In celebration of the Jesuit’s powder: a history of malaria treatment [J]. Lancet, 2015, 15: 1143.
[7]	Gachelin G, Garner P, Ferroni E, et al. Evaluating Cinchona bark and quinine for treating and prventing malaria [J]. J R Soc Med, 2017, 110(1) 31-40.
[8]	Brabin B. Malaria’s contribution to World War One-the unexpected adversary [J]. Malar J, 2014, 13, 497.
[9]	Slater A, Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites[J]. Nature,1992, 355: 167-169.
[10]	Olafsona K N, Nguyena T Q , Jeffrey D, et al. Antimalarials inhibit hematin crystallization by unique drug-surface site interactions[J]. Proc Natl Acad Sci USA, 2017, 114: 7531-7536.
[11]	Ramanna M, Nasarwanji H, Choksy (1861-1939). A pioneer of controlled clinical trials. JLL Bulletin: Commentaries on the history of treatment evaluation, 2014. www.jameslindlibrary.org/articles/nasarwanji-hormusji-choksy-1861-1939-a-pio-neer-of-controlled-clinical-trials/ (last checked 13 November 2016).
[12]	Liles N W, Page E E,. Liles A L, et al . Diversity and severity of adverse reactions to quinine: a systematic review[J]. Am J Hematol, 2016, 91: 461-466.
[13]	Reva C L, David T F, Charles G H,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I[J]. Arthritis Rheum, 2007, 58:15-25.
[14]	Marks J. S. Motor polyneuroapthy and nystagmus associated with chloroquine phosphate[J]. Postgrad Med J, 1979, 55(646): 569.
[15]	Durcan L, Petri M. Immunomodulators in SLE: clinical evidence and immunologic actions[J]. J Autoimmun, 2016,74: 73-84.
[16]	Julie B, Nathalie C C, Adey B. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus [J]. Ann Rheum Dis, 77(12): 1742-1749.
[17]	Graciela S A, Gerald M, Ana M, et al Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) [J]. Ann Rheum Dis, 2007, 66(9): 1168-1172.
[18]	Kroese S, Hair J. Hydroxychloroquine Use in Lupus patients during pregnancy is associated with longer pregnancy duration in preterm births [J]. J Immunol Res, 2017, 2017: 2810202.
[19]	Jacob H R, Wu Xiao-Xuan. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein-I complexes to phospholipid bilayers [J]. Blood, 2008, 112(5): 1687-1695.
[20]	O’Dell J R, Mikuls T R, Taylor T H, et al. Therapies for active rheumatoid arthritis after methotrexate failure[J]. N Engl J Med, 2013, 369(4): 307-318.
[21]	WANG S Q, ZHANG L W, WEI P. Is hydroxychloroquine effective in treating primary Sjogren’s syndrome: a systematic review and meta-analysis [J]. BMC Musculoskelet Disord, 2017, 18: 186.
[22]	Fazlollah K. Fungistatic effect of hydroxychloroquine, lessons from a case [J]. Med Mycol Case Rep, 2016, 13: 17-18.
[23]	Marcos C B,Luiza A, Castro B, et al. Chloroquine use improves dengue-related symptoms[J]. Mem Inst Oswaldo Cruz, 2013, 108(5): 596-599.
[24]	Andrea S, Iart L S. Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS [J]. Retrovirology, 2015, 12: 51.
[25]	Helal G K, Gad M A, Abd-Ellah M F, et al. Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients[J]. J Med Virol,2016,88:2170-2178.
[26]	Solomon D H, Garg R, LIU B, et al. The effect of hydroxychloroquine on insulin sensitivity and lipid parameters in non-diabetic patients with rheumatoid arthritis: a randomized blinded cross-over trial arthritis [J]. Care Res (Hoboken), 2015, 66(8): 1246-1251.
[27]	Arielle U, Nicholas T, Cristina S, et al. Inflammation beyond the joints:rheumatoid arthritis and cardiovascular disease[J]. J Cardiol,2018,2(3):1000019.
[28]	Jose F R, Inmaculada R, Emily M, et al.Use of hydroxychloroquine is associated with improved lipid profile in rheumatoid arthritis patients[J]. J Clin Rheumatol, 2017, 23(3): 144-148.
[29]	Li X F, Burton E M, Bhaduri-McIntosh S, et al . Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells [J]. PLoS Pathog, 2017, 13(3): e1006249.
[30]	Jia Lihua, Wang Juan, Wu Tong. In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma[J]. Mol Med Rep, 2017, 16(5): 5779-5786.
[31]	刘佳,陈芳源,王海嵘. 磷酸氯喹诱导 U937细胞凋亡机制的研究[J]. 上海交通大学学报 (医学版),2009, 29(7): 813-816
[32]	Chen Degao, Xie Jing, Roland F, et al. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype [J]. Nat Commun, 2018, 9: 873.
[33]	Melisa N, Taylor S B, Paul E, et al. Are long-term chloroquine or hydroxychloroquine users being checked regularly for toxic maculopathy?[J]. JAMA Ophthalmol, 2014,132(10): 1199-1208.
[34]	Martin J V, Bergeron E, Suzanne B, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread[J]. Virol J, 2005, 2: 69.
[35]	Rodrigo D, Luiza M. H, Paula P. et al. Chloroquine, an endocytosis blocking agent, inhibits Zika Virus infection in different cell models[J]. Viruses,2016, 8(12): 322.
[36]	De Wilde A H, Jochmans D, Posthuma C C, et al. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture[J]. Antimicrob Agents Chemother, 2014, 58(8):4875-4884.
[37]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 2020, 6736(20): 30183-30185.
[38]	Steinbuch Y. Chinese baby tests positive for Coronavirus 30 hours after birth[N/OL]. (ac-cessed on 9 February 2020),Available online: https://nypost.com/2020/02/05/chinese-baby-tests-positive-for-coronavirus-30-hours-after-birth/.
[39]	Gillespie T. Coronavirus: doctors fear pregnant women can pass on illness after newborn baby is diagnosed[N/OL]. (accessed on 8 February 2020), Available online: https://news.sky.com/story/coronavirus-doctors-fear-pregnant-women-can-pass-on-illness-after-newborn-baby-is-diagnosed-11926968.